Harvard Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2008 | — | — | $13.7M |
| FY2009 | — | — | $16.6M |
| FY2010 | $34.5M | $124.8M | $19.7M |
| FY2011 | $31.1M | $126.6M | $17.9M |
| FY2012 | $29.3M | $133.5M | $20.7M |
| FY2013 | $41.0M | $135.5M | $25.8M |
| FY2014 | $40.4M | $135.9M | $14.1M |
| FY2015 | $42.5M | $120.1M | $6.7M |
| FY2016 | $35.6M | $107.8M | $5.6M |
| FY2017 | $28.5M | $109.4M | $5.2M |
| FY2018 | $85.9M | $168.6M | $8.2M |
| FY2019 | $83.2M | $164.9M | $8.3M |
| FY2020 | $79.6M | $156.3M | $8.3M |
| FY2021 | $78.9M | $162.3M | $7.8M |
| FY2022 | $73.1M | $145.4M | $4.5M |
| FY2023 | $64.3M | $137.4M | $4.3M |
| FY2024 | $63.3M | $126.6M | $4.1M |
| FY2025 | $66.3M | $80.1M | $8.6M |